GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 6,130.00
+80.00 (1.32%)
At close: Mar 19, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 209.12 billion as of March 20, 2026. Its market cap has increased by 367.91% in one year.
Market Cap
209.12B
Enterprise Value
204.63B
Revenue
8.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,130.00
Market Cap Chart
Since November 8, 2021, GENINUS's market cap has increased from 145.65B to 209.12B, an increase of 43.58%. That is a compound annual growth rate of 8.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 209.12B | 79.14% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | 145.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 481.82B |
| Dx & Vx | 441.94B |
| HLB Panagene | 117.54B |
| Cytogen | 104.62B |
| Green Cross Medical Science | 80.23B |
| Protia | 64.19B |
| Seoulin Bioscience | 57.20B |
| GeneMatrix | 42.62B |